Fortive Corp: Form 10-Q for the period ended Sep 27, 2019
Filed with the SEC on Oct 25, 2019 and accepted by EDGAR at Oct 24, 2019, 19:01 ET.
Management's discussion and analysis
As filed, 60,816 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Fortive Corporation (“Fortive,” the “Company,” “we,” “us,” or “our”) is a diversified industrial technology growth company comprised of Professional Instrumentation and Industrial Technologies segments and encompassing businesses that are recognized leaders in attractive markets. Our well-known brands hold leading positions in advanced instrumentation and solutions, sensing, transportation technology, and franchise distribution markets. Our businesses design, develop, service, manufacture and market professional and engineered products, software and services for a variety of end markets, building upon leading brand names, innovative technology and significant market positions.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of management. The following discussion should be read in conjunction with the MD&A and consolidated and combined financial statements included in our 2018 Annual Report on Form 10-K. Our MD&A is divided into five sections:
- Information Relating to Forward-Looking Statements
- Overview
- Results of Operations
- Liquidity and Capital Resources
- Critical Accounting Estimates
INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this quarterly report, in other documents we file with or furnish to the Securities and Exchange Commission (“SEC”), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are “forward-looking statements” within the meaning of the United States federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, separation into two independent, publicly traded companies, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; impact on changes to tax laws; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words.
Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors. Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Important factors that could cause actual results to differ materially from those envisaged in the forward-looking statements include the following:
- Conditions in the global economy, the markets we serve and the financial markets may adversely affect our business and financial statements.
- Our growth could suffer if the markets into which we sell our products, software and services decline, do not grow as anticipated or experience cyclicality.
- We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce prices for our products and services.
- Changes in industry standards and governmental regulations may reduce demand for our products or services or increase our expenses.
- Trade relations between China and the United States could have a material adverse effect on our business and financial statements.
- Any inability to consummate acquisitions at our anticipated rate and at appropriate prices could negatively impact our growth rate and stock price.
- Our growth depends in part on the timely development and commercialization, and customer acceptance, of new and enhanced products and services based on technological innovation.
- Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
- Our acquisition of businesses, joint ventures and strategic relationships could negatively impact our financial statements.
- Our plans to separate into two independent, publicly traded companies may encounter unexpected delays and may not be completed on the currently contemplated timeline or at all and may not achieve the intended benefits.
- The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
- Divestitures or other dispositions could negatively impact our business, and contingent liabilities from businesses that we have sold could adversely affect our financial statements.
- Our operations, products and services expose us to the risk of environmental, health and safety liabilities, costs and violations that could adversely affect our reputation and financial statements.
- Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our financial statements and reputation.
- International economic, political, legal, compliance and business factors could negatively affect our business and financial statements.
- We may be required to recognize impairment charges for our goodwill and other intangible assets.
- Foreign currency exchange rates may adversely affect our financial statements.
- Changes in our effective tax rates or exposure to additional income tax liabilities or assessments could affect our profitability. In addition, audits by tax authorities could result in additional tax payments for prior periods.
- We have incurred a significant amount of debt, and our debt will increase further if we incur additional debt and do not retire existing debt.
- We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our financial statements.
- If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
- Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
- A significant disruption in, or breach in security of, our information technology systems could adversely affect our business.
- Defects and unanticipated use or inadequate disclosure with respect to our products (including software) or services could adversely affect our business, reputation and financial statements.
- Adverse changes in our relationships with, or the financial condition, performance, purchasing patterns or inventory levels of, key distributors and other channel partners could adversely affect our financial statements.
- Our financial results are subject to fluctuations in the cost and availability of commodities that we use in our operations.
- If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer. In addition, our reliance upon sole or limited sources of supply for certain materials, components and services could cause production interruptions, delays and inefficiencies.
- Our restructuring actions could have long-term adverse effects on our business.
- Work stoppages, union and works council campaigns and other labor disputes could adversely impact our productivity and results of operations.
- If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
- Certain provisions in our amended and restated certificate of incorporation and bylaws, and of Delaware law, may prevent or delay an acquisition of our company, which could decrease the trading price of our common stock.
- Changes in U.S. GAAP could adversely affect our reported financial results and may require significant changes to our internal accounting systems and processes.
- Our amended and restated certificate of incorporation designates the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders, which could discourage lawsuits against us and our directors and officers.
- Certain of our executive officers and directors may have actual or potential conflicts of interest because of their equity interest in Danaher.
- Potential liabilities may arise due to fraudulent transfer considerations, which would adversely affect our financial condition and our results of operations.
- International economic, political, legal, compliance and business factors could negatively affect our financial statements.
- The interest rates on our credit facilities may be impacted by the phase out of the London Interbank Offered Rate (“LIBOR”).
See “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and Form 10-Q for the fiscal quarter ended June 28, 2019 and “Part II - Item 1A. Risk Factors” in this Form 10-Q for a further discussion regarding reasons that actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Forward-looking statements speak only as of the date of the report, document, press release, webcast, call, materials or other communication in which they are made. We do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
OVERVIEW
General
Fortive is a diversified, multinational industrial technology growth company with global operations and our businesses are affected by worldwide, regional and industry-specific economic and political factors. Our geographic and industry diversity, as well as the range of our products, software and services, typically help limit the impact of any one industry or the economy of any single country (except for the United States) on our operating results. Given the broad range of products manufactured, software and services provided and geographies served, we do not use any indices other than general economic trends to predict the overall outlook for the Company. Our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.
As a result of our geographic and industry diversity, we face a variety of opportunities and challenges, including technological development in most of the markets we serve, the expansion and evolution of opportunities in high-growth markets, trends and costs associated with a global labor force and consolidation of our competitors. We define high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia with the exception of Japan and Australia. We operate in a highly competitive business environment in most markets, and our long-term growth and profitability will depend in particular on our ability to expand our business across geographies and market segments, identify, consummate and integrate appropriate acquisitions, develop innovative and differentiated new products, services and software, expand and improve the effectiveness of our sales force and continue to reduce costs and improve operating efficiency and quality, and effectively address the demands of an increasingly regulated environment. We are making significant investments, organically and through acquisitions, to address technological change in the markets we serve and to improve our manufacturing, research and development and customer-facing resources in order to be responsive to our customers throughout the world.
On September 4, 2019, we announced our intention to separate into two independent, publicly traded companies subject to the satisfaction of certain conditions, including obtaining final approval from our Board of Directors. The separation will create (i) an industrial technology company, retaining the Fortive name, with a differentiated portfolio of growth-oriented businesses and (ii) a global industrial company (“NewCo”) focused on the growth opportunities in the rapidly evolving transportation and mobility markets. The separation is expected to be structured in a tax-efficient manner and completed in the second half of 2020. All assets, liabilities, revenues and expenses of NewCo are included in continuing operations of the Company in the accompanying consolidated condensed financial statements.
On July 20, 2019, we completed the combination of the Tektronix Video test and monitoring equipment business (“Tektronix Video Business”) with Telestream, LLC (the “Combined Business”), a portfolio company of Genstar Capital LLC. We recognized a pre-tax gain of $41.2 million upon the combination, and hold a 33% equity stake in the Combined Business. This transaction did not meet the criteria for discontinued operations reporting, and therefore the operating results of the Tektronix Video Business prior to the combination with Telestream are included in continuing operations for all periods presented. Additionally, the equity earnings from our stake in the Combined Business are included in other non-operating expenses, net in the accompanying Consolidated Condensed Statement of Earnings.
On April 1, 2019, we acquired the advanced sterilization products business (“ASP”) of Johnson & Johnson, a New Jersey corporation (“Johnson & Johnson”) for an aggregate purchase price of $2.7 billion (the “Transaction”), subject to certain post-closing adjustments set forth in a Stock and Asset Purchase Agreement, dated effective as of June 6, 2018 (the “Purchase Agreement”), between the Company and Ethicon, Inc., a New Jersey corporation (“Ethicon”) and a wholly owned subsidiary of Johnson & Johnson. ASP engages in the research, development, manufacture, marketing, distribution and sale of low-temperature terminal sterilization and high-level disinfection products. ASP generated annual revenues of approximately $800 million in 2018. Refer to Note 2 to the accompanying consolidated condensed financial statements for additional information regarding the Transaction.
On October 1, 2018, we completed the split-off of four of our operating companies (the “A&S Business”), and have reported the A&S Business as discontinued operations in our Consolidated Condensed Statements of Earnings, Consolidated Condensed Balance Sheets, and Consolidated Condensed Statements of Cash Flows for all periods presented. Unless otherwise noted discussion within this MD&A relates to continuing operations.
In this report, references to sales from existing businesses refers to sales from operations calculated according to generally accepted accounting principles in the United States (“GAAP”) but excluding (1) the impact from acquired businesses and (2) the impact of currency translation. References to sales attributable to acquisitions or acquired businesses refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition less the amount of sales attributable to certain divested businesses or product lines not considered discontinued operations prior to the first anniversary of the divestiture. The portion of sales attributable to the impact of currency translation is calculated as the difference between (a) the period-to-period change in sales (excluding sales impact from acquired businesses) and (b) the period-to-period change in sales (excluding sales impact from acquired businesses) after applying the current period foreign exchange rates to the prior year period. Sales from existing businesses should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies.
Management believes that reporting the non-GAAP financial measure of sales from existing businesses provides useful information to investors by helping identify underlying growth trends in our business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers. We exclude the effect of acquisitions and divestiture related items because the nature, size and number of such transactions can vary dramatically from period to period and between us and our peers. We exclude the effect of currency translation from sales from existing businesses because the impact of currency translation is not under management’s control and is subject to volatility. Management believes the exclusion of the effect of acquisitions and divestitures and currency translation may facilitate the assessment of underlying business trends and may assist in comparisons of long-term performance. References to sales volume refer to the impact of both price and unit sales.
Business Performance and Outlook
While differences exist among our businesses, on an overall basis, demand for our products, software and services increased during the three months ended September 27, 2019 as compared to the comparable period of 2018 resulting in aggregate year-over-year total sales growth of 16.2% and sales growth from existing businesses of 2.1%. Our continued application and deployment of the Fortive Business System including investments in sales growth initiatives and new product introductions, as well as increased demand in developed markets and other business-specific factors discussed below, contributed to overall sales growth from existing businesses across the majority of our businesses in the period.
On a year-over-year basis for the three months ended September 27, 2019, our Industrial Technologies segment reported sales growth from existing businesses of 6.5%, while our Professional Instrumentation segment reported a decline in sales from existing businesses of 1.3%. In our Industrial Technologies segment, the liability shift related to enhanced credit card security requirements for outdoor payment systems that is expected to occur in October 2020 in the United States based on the Europay, Mastercard and Visa (“EMV”) global standards is continuing to drive demand within our transportation technologies platform. The decline in our Professional Instrumentation segment reflects slowing macroeconomic conditions across most major markets.
Geographically, sales from existing businesses grew at a low-single digit rate in developed markets and declined at a low-single digit rate in high-growth markets during the three months ended September 27, 2019 as compared to the comparable 2018 period. Year-over-year sales from existing businesses grew at a low-double digit rate in Latin America and at a low-single digit rate in North America, while sales in Asia declined at a low-single digit rate during the three months ended September 27, 2019.
While we expect overall sales to continue to grow on a year-over-year basis during the remainder of 2019, we expect sales from existing businesses to be relatively flat as we continue to monitor macro-economic developments and the corresponding impact on our businesses. In addition, we continue to monitor geopolitical uncertainties, including Brexit and global uncertainties related to governmental policies toward international trade, monetary and fiscal policies; and the current uncertainty surrounding the relationship between the United States and China with respect to trade policies, treaties, government regulations, and tariffs. We will also continue to monitor other factors identified above in “—Information Relating to Forward-Looking Statements.”
RESULTS OF OPERATIONS
Sales Growth
The following tables summarize total aggregate year-over-year sales growth and the components of aggregate year-over-year sales growth during the three and nine months ended September 27, 2019 as compared to the comparable periods of 2018:
Components of Sales Growth
| % Change Three Months Ended September 27, 2019 vs. Comparable 2018 Period | % Change Nine Months Ended September 27, 2019 vs. Comparable 2018 Period | |
|---|---|---|
| Total revenue growth (GAAP) | 16.2% | 13.3% |
| Existing businesses (Non-GAAP) | 2.1% | 2.6% |
| Acquisitions (Non-GAAP) | 15.3% | 12.7% |
| Currency exchange rates (Non-GAAP) | (1.2)% | (2.0)% |
Operating Profit Margins
Operating profit margin was 13.0% for the three months ended September 27, 2019, a decrease of 460 basis points as compared to 17.6% in the comparable period of 2018. Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Higher 2019 sales volumes from existing businesses, price increases, and incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives which were more than offset by unfavorable
sales mix, increased material costs associated primarily with inflationary pressures and recently enacted tariffs, and changes in foreign currency exchange rates — unfavorable 25 basis points
- The incremental year-over-year net dilutive effect of acquired businesses — unfavorable 415 basis points
- The incremental year-over-year net dilutive effect of acquisition-related transaction costs and transaction costs related to the planned separation of Fortive into two independent, publicly traded companies — unfavorable 20 basis points
Operating profit margin was 13.3% for the nine months ended September 27, 2019, a decrease of 550 basis points as compared to 18.8% in the comparable period of 2018. Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Higher 2019 sales volumes from existing businesses, price increases, incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives which were more than offset by unfavorable sales mix, increased material costs associated primarily with inflationary pressures and recently enacted tariffs, and changes in foreign currency exchange rates — unfavorable 20 basis points
- The incremental year-over-year net dilutive effect of acquired businesses — unfavorable 400 basis points
- The incremental year-over-year net dilutive effect of acquisition-related transaction costs and transaction costs related to the planned separation of Fortive into two independent, publicly traded companies —unfavorable 130 basis points
Business Segments
Sales by business segment for each of the periods indicated were as follows ($ in millions):
| Three Months Ended September 27, 2019 | September 28, 2018 | Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|---|---|
| Professional Instrumentation | $1,116.2 | $894.1 | $3,196.8 | $2,654.8 |
| Industrial Technologies | 743.8 | 707.1 | 2,120.8 | 2,040.4 |
| Total | $1,860.0 | $1,601.2 | $5,317.6 | $4,695.2 |
PROFESSIONAL INSTRUMENTATION
Our Professional Instrumentation segment consists of our Advanced Instrumentation & Solutions and Sensing Technologies businesses. Our Advanced Instrumentation & Solutions businesses provide product realization and field solutions services and products. Field solutions products include a variety of compact professional test tools, thermal imaging and calibration equipment for electrical, industrial, electronic and calibration applications, online condition-based monitoring equipment; portable gas detection equipment, consumables, and software as a service (SaaS) offerings including safety/user behavior, asset management, and compliance monitoring; subscription-based technical, analytical, and compliance services to determine occupational and environmental radiation exposure; and software data analytics and services for critical infrastructure in utility, industrial, energy, construction, facilities management, public safety, mining, and healthcare applications. Product realization services and products help developers and engineers across the end-to-end product creation cycle from concepts to finished products and also include highly-engineered energetic materials components in specialized vertical applications. Our Sensing Technologies business offers devices that sense, monitor and control operational or manufacturing variables, such as temperature, pressure, level, flow, turbidity and conductivity. On April 1, 2019, we acquired the ASP business from Johnson & Johnson. ASP provides sterilization solutions to health care facilities used in the fields of low-temperature terminal sterilization and high-level disinfection.
Professional Instrumentation Selected Financial Data
($ in millions)
| Three Months Ended September 27, 2019 | September 28, 2018 | Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|---|---|
| Sales | $1,116.2 | $894.1 | $3,196.8 | $2,654.8 |
| Operating profit | 118.7 | 160.2 | 376.9 | 583.3 |
| Depreciation | 20.7 | 16.0 | 56.6 | 48.5 |
| Amortization | 73.9 | 24.8 | 187.3 | 58.4 |
| Operating profit as a % of sales | 10.6% | 17.9% | 11.8% | 22.0% |
| Depreciation as a % of sales | 1.9% | 1.8% | 1.8% | 1.8% |
| Amortization as a % of sales | 6.6% | 2.8% | 5.9% | 2.2% |
Components of Sales Growth
| % Change Three Months Ended September 27, 2019 vs. Comparable 2018 Period | % Change Nine Months Ended September 27, 2019 vs. Comparable 2018 Period | |
|---|---|---|
| Total revenue growth (GAAP) | 24.8% | 20.4% |
| Existing businesses (Non-GAAP) | (1.3)% | 0.2% |
| Acquisitions (Non-GAAP) | 27.2% | 22.1% |
| Currency exchange rates (Non-GAAP) | (1.1)% | (1.9)% |
Sales from existing businesses in our Professional Instrumentation segment’s Advanced Instrumentation & Solutions businesses decreased at a low-single digit rate during the three months ended September 27, 2019 and were relatively flat during the nine months ended September 27, 2019 as compared to the comparable periods of 2018.
Year-over-year sales from existing businesses of field solutions products and services declined at a low-single digit rate during the three months ended September 27, 2019 and were relatively flat during the nine months ended September 27, 2019, as growth in demand for portable gas detection and facilities maintenance and asset management offerings was more than offset by declines in demand for electrical grid condition-based monitoring equipment and slowing demand from our industrial channel partners in North America.
Year-over-year sales from existing businesses of product realization products and services decreased slightly during the three months ended September 27, 2019, as compared to the comparable period of 2018. For the three month period, increased demand in our energetic materials business was more than offset by slowing demand from our channel partners and decreased demand for our Keithley products and oscilloscopes. During the nine months ended September 27, 2019, year-over-year sales from existing businesses of product realization products and services increased slightly, driven by strong growth in our energetic materials business that was largely offset by declines in demand for our Keithley products.
Geographically, demand from existing businesses in Advanced Instrumentation & Solutions increased in Latin America, Japan, and China on a year-over-year basis during the three months ended September 27, 2019, which was more than offset by declines in North America. Demand from existing businesses increased on a year-over-year basis during the nine months ended September 27, 2019 in North America, China, and Japan, which was mostly offset by declines in Western Europe.
Sales from existing businesses in our segment’s Sensing Technologies businesses declined at a low-single digit rate during the three and nine months ended September 27, 2019 as compared to the comparable periods of 2018, as increased demand in the medical market was more than offset by declines in industrial end markets for both respective periods. Geographically, during the three months ended September 27, 2019, increased demand from existing businesses in North America and China was more than offset by declines in Western Europe, Korea, and Japan. For the year-to-date period, increased demand from existing businesses in China was more than offset by declines in North America, Japan, and Western Europe.
Sales from recently acquired businesses in our Professional Instrumentation segment, including ASP, Gordian and Accruent, contributed 27.2% and 22.1% to overall sales growth for the three and nine months ended September 27, 2019, respectively. ASP sales for the three months and nine months ended September 27, 2019, as compared to the comparable period prior to Fortive ownership, increased low-single digits which was attributable to growth in China and Japan for both periods. Gordian and Accruent sales for the three and nine months ended September 27, 2019, as compared to the comparable period prior to
Fortive ownership, increased mid-single digits in both periods attributable to growth in facilities maintenance and asset management offerings.
Year-over-year price increases in our Professional Instrumentation segment contributed 1.8% and 1.3% to sales growth during the three and nine months ended September 27, 2019, respectively, as compared to the comparable periods of 2018, and are reflected as a component of the change in sales from existing businesses.
Operating profit margin decreased 730 basis points during the three months ended September 27, 2019 as compared to the comparable period of 2018. Year-over-year operating profit margin comparisons were favorably impacted by:
- Acquisition-related transaction costs, as the costs related to our acquisition of ASP and acquisition-related restructuring in 2019, were less than the costs associated with the ASP, Gordian, and Accruent acquisitions in 2018 — favorable 150 basis points
Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Price increases and incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives that were more than offset by a decline in sales volumes, unfavorable sales mix, incremental year-over-year costs associated with sales and marketing growth initiatives, increased material costs associated primarily with inflationary pressures and recently enacted tariffs, and changes in currency exchange rates — unfavorable 180 basis points
- The incremental year-over-year net dilutive effect of acquired businesses, including amortization and acquisition-related fair value adjustments to deferred revenue and inventory — unfavorable 700 basis points
Operating profit margin decreased 1,020 basis points during the nine months ended September 27, 2019 as compared to the comparable period of 2018. Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Higher 2019 sales volumes from existing businesses, price increases and incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives that were more than offset by an unfavorable sales mix, increased material costs associated primarily with inflationary pressures and recently enacted tariffs, and changes in currency exchange rates — unfavorable 170 basis points
- The incremental year-over-year net dilutive effect of acquired businesses, including amortization and acquisition-related fair value adjustments to deferred revenue and inventory — unfavorable 680 basis points
- Acquisition-related transaction costs, as the costs related to our acquisition of ASP and acquisition-related restructuring in 2019, were less than the costs associated with the ASP, Gordian and Accruent acquisitions in 2018 — unfavorable 170 basis points
INDUSTRIAL TECHNOLOGIES
Our Industrial Technologies segment consists of our Transportation Technologies and Franchise Distribution businesses. Our Transportation Technologies business is a leading worldwide provider of solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment systems, environmental compliance, vehicle tracking and fleet management, and traffic management. Our Franchise Distribution business manufactures and distributes professional tools and a full-line of wheel service equipment.
Industrial Technologies Selected Financial Data
($ in millions)
| Three Months Ended September 27, 2019 | September 28, 2018 | Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|---|---|
| Sales | $743.8 | $707.1 | $2,120.8 | $2,040.4 |
| Operating profit | 146.0 | 141.7 | 404.2 | 370.5 |
| Depreciation | 13.9 | 13.7 | 40.0 | 40.5 |
| Amortization | 7.9 | 7.5 | 24.1 | 22.9 |
| Operating profit as a % of sales | 19.6% | 20.0% | 19.1% | 18.2% |
| Depreciation as a % of sales | 1.9% | 1.9% | 1.9% | 2.0% |
| Amortization as a % of sales | 1.1% | 1.1% | 1.1% | 1.1% |
38
Components of Sales Growth
| % Change Three Months Ended September 27, 2019 vs. Comparable 2018 Period | % Change Nine Months Ended September 27, 2019 vs. Comparable 2018 Period | |
|---|---|---|
| Total revenue growth (GAAP) | 5.2% | 3.9% |
| Existing businesses (Non-GAAP) | 6.5% | 5.7% |
| Acquisitions (Non-GAAP) | 0.1% | 0.5% |
| Currency exchange rates (Non-GAAP) | (1.4)% | (2.3)% |
Sales from existing businesses in our Transportation Technologies businesses grew high-single digits during both the three and nine months ended September 27, 2019 as compared to the comparable periods of 2018. Geographically, demand from existing businesses increased in North America and Western Europe and was partially offset by declines in Asia during both the three and nine months ended September 27, 2019. The results in both periods were largely attributable to broad based demand for fuel management systems, specifically in North America and Europe, as well as demand for payment solutions. In addition, demand for fuel management systems in China contributed to growth during the nine months ended September 27, 2019. Sales from existing businesses in North America were favorably impacted in both periods by the approaching deadline of the liability shift related to the outdoor EMV global standards.
Sales from existing businesses in our Franchise Distribution businesses increased at a low-single digit rate during the three months ended September 27, 2019 and were relatively flat during the nine months ended September 27, 2019, as compared to the comparable periods of 2018. The results in both periods were due to increased demand for hardline tools and shop equipment that was largely offset by declines in wheel service equipment.
Year-over-year price increases in our Industrial Technologies segment contributed 1.1% and 1.9% to sales growth during the three and nine months ended September 27, 2019, respectively, as compared to the comparable periods of 2018, and are reflected as a component of the change in sales from existing businesses.
Operating profit margin decreased 40 basis points during the three months ended September 27, 2019 as compared to the comparable period of 2018. Year-over-year operating profit margin comparisons were favorably impacted by:
- Higher 2019 sales volumes from existing businesses, price increases, favorable sales mix, and incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives that were partially offset by increased material costs associated primarily with inflationary pressures and recently enacted tariffs and changes in foreign currency exchange rates — favorable 190 basis points
Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Transaction costs related to the planned separation of Fortive into two independent, publicly traded companies — unfavorable 230 basis points
Operating profit margin increased 90 basis points during the nine months ended September 27, 2019 as compared to the comparable period of 2018. Year-over-year operating profit margin comparisons were favorably impacted by:
- Higher 2019 sales volumes from existing businesses, price increases, and incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives that were partially offset by increased material costs associated primarily with inflationary pressures and recently enacted tariffs and changes in foreign currency exchange rates — favorable 190 basis points
Year-over-year operating profit margin comparisons were unfavorably impacted by:
- Transaction costs related to the planned separation of Fortive into two independent, publicly traded companies — unfavorable 90 basis points
- The incremental year-over-year net dilutive effect of acquired businesses — unfavorable 10 basis points
COST OF SALES AND GROSS PROFIT
($ in millions)
| Three Months Ended September 27, 2019 | September 28, 2018 | Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|---|---|
| Sales | $1,860.0 | $1,601.2 | $5,317.6 | $4,695.2 |
| Cost of sales | (932.3) | (775.3) | (2,673.2) | (2,272.2) |
| Gross profit | $927.7 | $825.9 | $2,644.4 | $2,423.0 |
| Gross profit margin | 49.9% | 51.6% | 49.7% | 51.6% |
The year-over-year increase in cost of sales during the three and nine months ended September 27, 2019, as compared to the comparable periods in 2018, is due primarily to the impact of incremental cost of sales from our recently acquired businesses, higher year-over-year sales volumes from existing businesses, and increased material costs associated primarily with inflationary pressures and recently enacted tariffs that were partly offset by cost savings associated with restructuring and productivity improvement initiatives, material cost and supply chain improvement actions, and changes in currency exchange rates.
The year-over-year increase in gross profit for the three and nine months ended September 27, 2019, as compared to the comparable periods in 2018, is due primarily to the favorable impact of pricing improvements from existing businesses, higher year-over-year sales volumes, including sales volumes from our recently acquired businesses, incremental year-over-year cost savings associated with restructuring and productivity improvement initiatives, and material cost and supply chain improvement actions. These factors were partially offset by increased material costs associated primarily with inflationary pressures and recently enacted tariffs and changes in currency exchange rates.
The respective 170 basis point and 190 basis point decrease in gross profit margins for the three and nine months ended September 27, 2019, as compared to the comparable periods in 2018, is due primarily to unfavorable sales mix, acquisition-related fair value adjustments to deferred revenue and inventory, and increased material costs associated primarily with inflationary pressures and recently enacted tariffs. We expect the acquisition-related fair value adjustments to deferred revenue to continue to impact margins during the remainder of 2019.
OPERATING EXPENSES
($ in millions)
| Three Months Ended September 27, 2019 | September 28, 2018 | Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|---|---|
| Sales | $1,860.0 | $1,601.2 | $5,317.6 | $4,695.2 |
| Selling, general and administrative (“SG&A”) expenses | 566.5 | 440.6 | 1,590.0 | 1,233.6 |
| Research and development (“R&D”) expenses | 119.1 | 103.7 | 345.5 | 305.5 |
| SG&A as a % of sales | 30.5% | 27.5% | 29.9% | 26.3% |
| R&D as a % of sales | 6.4% | 6.5% | 6.5% | 6.5% |
SG&A expenses increased during the three and nine months ended September 27, 2019, as compared to the comparable periods of 2018, due to higher amortization and incremental expenses from our recently acquired businesses, costs associated with the ASP acquisition and the planned separation of Fortive into two independent, publicly traded companies, and sales and marketing growth initiatives, partially offset by year-over-year cost savings associated with restructuring and productivity improvement initiatives and changes in currency exchange rates for both respective periods.
On a year-over-year basis, SG&A expenses as a percentage of sales increased 300 basis points and 360 basis points in the three and nine months ended September 27, 2019, respectively, due to higher amortization and relative spending levels at our recently acquired businesses, costs associated with the ASP acquisition and the planned separation of Fortive into two independent, publicly traded companies, and sales and marketing growth initiatives for both periods.
R&D expenses (consisting principally of internal and contract engineering personnel costs) increased during the three and nine months ended September 27, 2019, as compared to the comparable periods of 2018, due to incremental year-over-year investments in product development initiatives and incremental expenses from our recently acquired businesses. On a year-over-year basis, R&D expenses as a percentage of sales were relatively flat during the three and nine months ended September 27, 2019.
INTEREST COSTS
For a discussion of our outstanding indebtedness, refer to Note 6 to the accompanying consolidated condensed financial statements.
Net interest expense for the three and nine months ended September 27, 2019 was $47 million and $117 million, respectively. Net interest expense for the three and nine months ended September 28, 2018 was $23 million and $70 million, respectively. The increase in interest expense for both periods was due to higher year-over-year average debt balances used to fund acquisitions.
INCOME TAXES
Our effective tax rates for the three and nine months ended September 27, 2019 were 11.8% and 13.5%, respectively, as compared to 17.0% and 16.4% for the three and nine months ended September 28, 2018, respectively. The year-over-year decrease was due primarily to increases in favorable impacts of certain federal and international tax benefits and favorable impacts of a higher mix of income in jurisdictions with lower tax rates than the U.S. federal statutory rate of 21%.
Our effective tax rate for 2019 and 2018 differs from the U.S. federal statutory rate of 21% due primarily to the positive and negative effects of the Tax Cuts and Jobs Act (“TCJA”), U.S. federal permanent differences, the impact of credits and deductions provided by law, and earnings outside the United States that are indefinitely reinvested and taxed at rates lower than the U.S. federal statutory rate.
COMPREHENSIVE INCOME
Comprehensive income decreased by $67 million during the three months ended September 27, 2019 as compared to the comparable period in 2018 due primarily to net earnings that were lower by $38 million and unfavorable changes in foreign currency translation adjustments of $29 million.
Comprehensive income decreased by $203 million during the nine months ended September 27, 2019 as compared to the comparable period in 2018 due primarily to net earnings that were lower by $255 million, partially offset by favorable changes in foreign currency translation adjustments of $53 million.
INFLATION
The effect of inflation on our sales and net earnings was not significant in the three and nine month periods ended September 27, 2019.
LIQUIDITY AND CAPITAL RESOURCES
We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. We generate substantial cash from operating activities and expect that our operating cash flow and other sources of liquidity will be sufficient to allow us to continue to invest in existing businesses, consummate strategic acquisitions, make interest payments on our outstanding indebtedness, and manage our capital structure on a short and long-term basis.
Overview of Cash Flows and Liquidity
Following is an overview of our cash flows and liquidity for the nine months ended September 27, 2019:
($ in millions)
| Nine Months Ended September 27, 2019 | September 28, 2018 | |
|---|---|---|
| Total operating cash provided by continuing operations | $800.4 | $778.9 |
| Cash paid for acquisitions, net of cash received | $(3,387.7) | $(2,825.2) |
| Payments for additions to property, plant and equipment | (79.6) | (76.8) |
| All other investing activities | — | 4.0 |
| Total investing cash used in continuing operations | $(3,467.3) | $(2,898.0) |
| Net proceeds from (repayments of) commercial paper borrowings | $695.5 | $(64.3) |
| Proceeds from borrowings (maturities longer than 90 days), net of issuance costs of $24.3 million for the nine months ended September 27, 2019 | 2,413.2 | 1,750.0 |
| Repayment of borrowings (maturities greater than 90 days) | (455.3) | (725.0) |
| Proceeds from issuance of mandatory convertible preferred stock net of $43.0 million of issuance costs | — | 1,337.4 |
| Payment of common stock cash dividend to shareholders | (70.3) | (73.2) |
| Payment of mandatory convertible preferred stock cash dividend to shareholders | (34.5) | (17.6) |
| All other financing activities | 16.4 | 27.2 |
| Total financing cash provided by continuing operations | $2,565.0 | $2,234.5 |
Operating Activities
Cash flows from operating activities can fluctuate significantly from period-to-period as working capital needs and the timing of payments for income taxes, various employee liabilities, restructuring activities and other items impact reported cash flows.
Cash flows from operating activities were approximately $800 million during the first nine months of 2019, an increase of $22 million, as compared to the comparable period of 2018. The year-over-year change in operating cash flows was primarily attributable to the following factors:
- 2019 operating cash flows were impacted by lower net earnings for the first nine months of 2019 as compared to the comparable period in 2018. Net earnings for the nine months ended September 27, 2019 were impacted by a year-over-year decrease in operating profits of $175 million and an increase in net interest expense of $46 million associated with our financing activities related to recent acquisitions that were partially offset by the non-cash $41 million gain on the combination of our Tektronix Video Business with Telestream, LLC. The year-over-year decrease in operating profit was also impacted by costs associated with both the planned separation of Fortive into two independent, publicly traded companies and the transaction and integration costs associated with the ASP acquisition, and a net year-over-year increase in depreciation and amortization expenses of $137 million largely attributable to recently acquired businesses. Depreciation and amortization are noncash expenses that decrease earnings without a corresponding impact to operating cash flows.
- The aggregate of accounts receivable, inventories and trade accounts payable used $72 million of cash during the first nine months of 2019 as compared to using $118 million in the comparable period of 2018. The amount of cash flow generated from or used by the aggregate of accounts receivable, inventories and trade accounts payable depends upon how effectively we manage the cash conversion cycle, which effectively represents the number of days that elapse from the day we pay for the purchase of raw materials and components to the collection of cash from our customers, and can be significantly impacted by the timing of collections and payments in a period. The use of cash during the first nine months of 2019 was largely due to our working capital management, partially offset by the acquisition of ASP, as we did not acquire accounts receivable and accounts payable from Johnson & Johnson. We expect ASP to continue to invest in working capital throughout 2019.
- The aggregate of prepaid expenses and other assets and accrued expenses and other liabilities provided $12 million of cash during the first nine months of 2019 as compared to providing $8 million of cash in the comparable period
of 2018. The year over year change was largely driven by the timing of tax payments and various employee benefit accruals.
Investing Activities
Cash flows relating to investing activities consist primarily of cash used for acquisitions and capital expenditures. Net cash used in investing activities increased $569 million during the nine months ended September 27, 2019 as compared to the comparable period of 2018, due primarily to business acquisitions completed in 2019.
Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting product development initiatives, improving information technology systems and purchasing equipment that is used in revenue arrangements with customers. For the full year 2019, we expect capital spending to be between approximately $125 million and $135 million, which includes approximately $20 million of one-time capital expenditures related to the integration of the ASP acquisition. Actual expenditures will ultimately depend on business conditions.
Financing Activities and Indebtedness
Cash flows from financing activities consist primarily of cash flows associated with the issuance of equity, the issuance and repayments of debt and commercial paper, and payments of quarterly cash dividends to shareholders. Financing activities generated cash of $2.6 billion during the nine months ended September 27, 2019, of which $1.4 billion was due to the issuance of our 0.875% senior convertible notes and $1.0 billion was related to the issuance of our 364-day delayed-draw term loan facility due in 2020 (“2020 Delayed-Draw Term Loan”), which was partially offset by the repayment of $400 million of our 2019 delayed draw term loan and $55 million of our 1.80% senior unsecured notes. In the comparable 2018 period, financing activities generated cash of approximately $2.2 billion. In the nine months ended September 27, 2019, we made net borrowings of commercial paper under the U.S. and Euro commercial paper programs (“Commercial Paper Programs”) of $696 million and paid $105 million of cash dividends to shareholders of our common stock and MCPS.
Convertible Senior Notes
On February 22, 2019, we issued $1.4 billion in aggregate principal amount of our 0.875% Convertible Senior Notes due 2022 (the “Convertible Notes”), including $187.5 million in aggregate principal amount resulting from an exercise in full of an over-allotment option, to fund, in part, the ASP acquisition. The Convertible Notes bear interest at a rate of 0.875% per year, payable semiannually in arrears on February 15 and August 15 of each year, beginning on August 15, 2019. The Convertible Notes mature on February 15, 2022, unless earlier repurchased or converted in accordance with their terms prior to such date.
The Convertible Notes are convertible into shares of our common stock at an initial conversion rate of 9.3777 shares per $1,000 principal amount of Convertible Notes (which is equivalent to an initial conversion price of $106.64 per share), subject to adjustment upon the occurrence of certain events. The initial conversion price represents a premium of approximately 32.5% to the $80.48 per share closing price of our common stock on February 19, 2019. Upon conversion of the Convertible Notes, holders will receive cash, shares of our common stock, or a combination thereof, at our election. Our current intention is to settle such conversions through cash up to the principal amount of the converted Convertible Notes and, if applicable, through shares of our common stock for conversion value, if any, in excess of the principal amount of the converted Convertible Notes.
Delayed-Draw Term Loan Due 2020
On March 1, 2019, we entered into the credit facility agreement that provides for a 364-day delayed-draw term loan facility in an aggregate principal amount of $1.0 billion. On March 20, 2019, we drew down the full $1.0 billion available under the 2020 Delayed-Draw Term Loan in order to fund, in part, the ASP Acquisition. The 2020 Delayed-Draw Term Loan bears interest at a variable rate equal to the London inter-bank offered rate plus a ratings based margin currently at 75 basis points. As of September 27, 2019, borrowings under this facility bore an interest rate of 2.78% per annum. The 2020 Delayed-Draw Term Loan is prepayable at our option, and we are not permitted to re-borrow once the term loan is repaid. The terms and conditions, including covenants, applicable to the 2020 Delayed-Draw Term Loan are substantially similar to those applicable to the Revolving Credit Facility.
We generally expect to satisfy any short-term liquidity needs that are not met through operating cash flows and available cash primarily through issuances of commercial paper under the Commercial Paper Programs. Credit support for the Commercial Paper Programs is provided by our five-year, $2.0 billion senior unsecured revolving credit facility that expires on November 30, 2023 (“Revolving Credit Facility”). We classified our borrowings outstanding under the Commercial Paper Programs as long-term debt in the accompanying Consolidated Condensed Balance Sheet as of September 27, 2019, as we have the intent and ability, as supported by availability under the Revolving Credit Facility, to refinance these borrowings for at least one year from the balance sheet date. As commercial paper obligations mature, we may issue additional short-term commercial paper obligations to refinance all or part of these borrowings.
We had $2.0 billion available under the Revolving Credit Facility as of September 27, 2019. Of this amount, approximately $1.3 billion was being used to backstop outstanding U.S. and Euro commercial paper balances. Accordingly, we had the ability to incur an additional $656 million of indebtedness under the Revolving Credit Facility as of September 27, 2019. Refer to Note 6 of the consolidated condensed financial statements for information regarding our financing activities and indebtedness.
The availability of the Revolving Credit Facility as a standby liquidity facility to repay maturing commercial paper is an important factor in maintaining the existing credit ratings of the Commercial Paper Programs. We expect to limit any borrowings under the Revolving Credit Facility to amounts that would leave sufficient credit available under the facility to allow us to borrow, if needed, to repay all of the outstanding commercial paper as it matures.
As of September 27, 2019, commercial paper outstanding under the U.S. dollar-denominated commercial paper program had an annual effective rate of 2.34% and a weighted average remaining maturity of approximately 15 days. As of September 27, 2019, commercial paper outstanding under the Euro-denominated commercial paper program had an annual effective rate of (0.10)% and a weighted average remaining maturity of approximately 39 days.
Pursuant to our term loan agreement, $1.0 billion of our long-term debt is scheduled for maturity and repayment within 12 months. Accordingly, we have classified this as current debt on the accompanying Consolidated Condensed Balance Sheet.
Dividends
Aggregate cash payments for preferred and common stock dividends paid to shareholders during the nine months ended September 27, 2019 were $105 million and were recorded as dividends to shareholders in the Consolidated Condensed Statement of Changes in Equity and the Consolidated Condensed Statement of Cash Flows.
Cash and Cash Requirements
As of September 27, 2019, we held approximately $1.1 billion of cash and cash equivalents that were invested in highly liquid investment-grade instruments with a maturity of 90 days or less with an annual effective interest rate that approximated 0.6% during the three months ended September 27, 2019. Approximately 90% of the $1.1 billion of cash and cash equivalents we held as of September 27, 2019 was held outside of the United States.
We have cash requirements to support working capital needs, capital expenditures and acquisitions, pay interest and service debt, pay taxes and any related interest or penalties, fund our restructuring activities and pension plans as required, pay dividends to shareholders and support other business needs or objectives. With respect to our cash requirements, we generally intend to use available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, particularly in connection with acquisitions, we may also borrow under our commercial paper programs or credit facilities, enter into new credit facilities and either borrow directly thereunder or use such credit facilities to backstop additional borrowing capacity under our commercial paper programs and/or access the capital markets. We also may from time to time access the capital markets, including to take advantage of favorable interest rate environments or other market conditions.
The TCJA eliminated the U.S. tax cost for qualified repatriation beginning in 2018. Foreign cumulative earnings remain subject to foreign remittance taxes. We have made an election regarding the amount of earnings that we do not intend to repatriate due to local working capital needs, local law restrictions, high foreign remittance costs, previous investments in physical assets and acquisitions, or future growth needs. For most of our foreign operations, we make an assertion regarding the amount of earnings in excess of intended repatriation that are expected to be held for indefinite reinvestment. No provisions for foreign remittance taxes have been made with respect to earnings that are planned to be reinvested indefinitely. The amount of foreign remittance taxes that may be applicable to such earnings is not readily determinable given local law restrictions that may apply to a portion of such earnings, unknown changes in foreign tax law that may occur during the applicable restriction periods caused by applicable local corporate law for cash repatriation, and the various tax planning alternatives we could employ if we repatriated these earnings.
As of September 27, 2019, we expect to have sufficient liquidity to satisfy our cash needs for the foreseeable future, including our cash needs in the United States.
CRITICAL ACCOUNTING ESTIMATES
There were no material changes during the three and nine month periods ended September 27, 2019 to the items we disclosed as our critical accounting estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2018 Annual Report on Form 10-K.
Market risk
As filed, 389 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Financial Instruments and Risk Management,” in our 2018 Annual Report on Form 10-K. There were no material changes during the three months ended September 27, 2019 to the information reported in our 2018 Annual Report on Form 10-K.
Controls and procedures
As filed, 977 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our management, with the participation of the President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, these disclosure controls and procedures were effective.
There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 1,791 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Information regarding risk factors appears in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Information Relating to Forward-Looking Statements,” in Part I - Item 2 of this Form 10-Q and in the “Risk Factors” section of our 2018 Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended June 28, 2019 (the “Prior 10-Q”). Other than as provided below, there were no material changes during the quarter ended September 27, 2019 to the risk factors reported in the “Risk Factors” section of our 2018 Annual Report on Form 10-K and the Prior 10-Q.
Our plans to separate into two independent, publicly traded companies may not be completed on the currently contemplated timeline or at all and may not achieve the intended benefits.
On September 4, 2019, we announced our intention to separate into two independent, publicly traded companies. The separation, if effectuated, will create, (i) an industrial technology company, retaining the Fortive name, with a differentiated portfolio of growth-oriented businesses and (ii) a global industrial company (“NewCo”) focused on the growth opportunities in the rapidly evolving transportation and mobility markets.
Our ability to effectuate the separation, the structure of the separation and the anticipated benefits of the separation may be adversely and materially impacted by adverse market conditions, possible delays in obtaining various tax rulings, regulatory approvals or clearances, uncertainty of the financial markets, our business performance and unanticipated delays in establishing infrastructure or processes for NewCo. In addition, the cost and resources required to effectuate the separation may be significantly higher than what we currently anticipate.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-06-29 to 2019-09-27 | $1.86bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-01-01 to 2019-09-27 | $5.32bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-06-29 to 2019-09-27 | $932.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-27 | $2.67bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-06-29 to 2019-09-27 | $927.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-27 | $2.64bn | us-gaap:GrossProfit |
| Research and development | 3 months2019-06-29 to 2019-09-27 | $119.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-27 | $345.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-06-29 to 2019-09-27 | $566.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-01-01 to 2019-09-27 | $1.59bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-06-29 to 2019-09-27 | $242.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-27 | $708.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-06-29 to 2019-09-27 | $47.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-01-01 to 2019-09-27 | $116.7m | us-gaap:InterestExpense |
| Income tax | 3 months2019-06-29 to 2019-09-27 | $27.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-27 | $85.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-06-29 to 2019-09-27 | $207.1m | us-gaap:ProfitLoss |
| Net income | 9 months2019-01-01 to 2019-09-27 | $546.1m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2019-06-29 to 2019-09-27 | $0.56 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-27 | $1.46 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-06-29 to 2019-09-27 | $0.56 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-27 | $1.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-06-29 to 2019-09-27 | 339,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-27 | 339,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-27 | $796.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-27 | $79.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-09-27 | $1.06bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-27 | $3.47bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-27 | $16.66bn | us-gaap:Assets |
| Current liabilities | At period end2019-09-27 | $2.92bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-09-27 | $5.02bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-09-27 | $1.00bn | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2019-09-27 | $7.15bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001659166-19-000227. Last ingested by Listed: Nov 2, 2026, 20:42 ET. Listed shows no prices and gives no investment advice.